Developing the same idea, Zhang et al. [243] have isolated HSP70–peptide complexes from DCs fused to murine breast cancer 4T1 cells and then encapsulated those complexes into nanoliposomes to improve their stability/bioavailability and enhance the antitumor immunity. The gene discussed is HSPA1A; the disease is breast carcinoma.